Recent Advances in Life Science Technologies

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across different technologies, including genetic testing for cancer, exosome technology capabilities, and gene delivery approaches. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered anim

Table of Contents

Recent Advances in Life Science TechnologiesInnovations in Life Science Technologies Hereditary Cancer Risk Assessment Using 30-gene TestNew Age Companies Aid in Drug Discovery Needs of PharmaceuticalsDiversified Stem Cell Lines to Increase Therapeutics across Major Disease AreasAddressing Age-related Diseases through Telomerase Reverse Transcriptase Gene DeliveryExosome Research Analysis and Industry InteractionsExosome Technology CapabilityIndustry Interactions

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.